CASI - CASI Pharma trades higher on insider buying

CASI Pharmaceuticals (CASI) has added ~8.0% in the pre-market after its Chairman/CEO Wei-wu He disclosed the purchase of 3M company shares in a regulatory filing submitted yesterday.Making the company’s first insider transaction for the year, Wei-wu He has bought 3M common stock at an average price of $2.05 per share for a total value of $6.2M.CASI, a biopharmaceutical company with a hematology-oncology therapeutic focus targeting the global markets including the U.S. and China recently closed an underwritten public offering of 15.8M shares at $2.05/share.

For further details see:

CASI Pharma trades higher on insider buying